Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study-Reference-Cited by-同舟云学术

Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study

Published:2016-12-14 Issue:8 Volume:27 Page:3156-3166
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Yoo Roh-Eul,Choi Seung Hong,Kim Tae Min,Park Chul-Kee,Park Sung-Hye,Won Jae-Kyung,Kim Il Han,Lee Soon Tae,Choi Hye Jeong,You Sung-Hye,Kang Koung Mi,Yun Tae Jin,Kim Ji-Hoon,Sohn Chul-Ho

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00330-016-4692-9/fulltext.html

Reference43 articles.

1. Haroon HA, Buckley DL, Patankar TA et al (2004) A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. J Magn Reson Imaging 19:527–536

2. Harrer JU, Parker GJ, Haroon HA et al (2004) Comparative study of methods for determining vascular permeability and blood volume in human gliomas. J Magn Reson Imaging 20:748–757

3. Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232

4. Jia Z, Geng D, Xie T, Zhang J, Liu Y (2012) Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging. J Clin Neurosci 19:820–823

5. Jung SC, Yeom JA, Kim JH et al (2014) Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading. AJNR Am J Neuroradiol 35:1103–1110

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of K^transderived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy;Journal for ImmunoTherapy of Cancer;2024-06

2. Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma;Cancers;2024-05-11

3. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma;Clinics;2024-01

4. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype;Journal of Neuro-Oncology;2023-09

5. Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma;Cancers;2022-08-03